Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) (NCT04938661) | Clinical Trial Compass
CompletedNot Applicable
Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)
United States206 participantsStarted 2021-07-08
Plain-language summary
The purpose of this research is to find out if doing cardiac rehab at home, or a mix of cardiac rehab at home and in the clinic, is as effective as coming in to the clinic for cardiac rehab.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Own or have reliable access to a smartphone or desktop computer with internet access
* Have an email address
* Patients who have a history of one of the following; acute myocardial infarction/acute coronary syndrome, stable angina pectoris, percutaneous coronary intervention, or heart failure.
* Patients who have undergone a surgical procedure which includes an indication for cardiac rehabilitation (coronary artery bypass surgery, heart valve repair/replacement, or heart transplant)
Exclusion Criteria:
* Patients referred to cardiac rehab with ventricular assist devices.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This iCARE trial used mobile case management to support cardiac rehabilitation — since the trial is already completed, has the data been published, and if so, did patients with my specific condition (like a recent heart attack or heart failure) actually show improvement in their exercise capacity measured by METs?
2The trial tracked how many participants were re-hospitalized during the study — is that safety and outcome data available for me to review with you, and does it suggest this mobile approach was as safe as standard in-person cardiac rehab?
3Since this was a 'Phase NA' behavioral/management trial rather than a drug trial, how does the mobile case management approach being tested here compare to the standard cardiac rehabilitation program you'd normally recommend for me?
4Adherence to the program was one of the main things being measured — based on what the trial found, do you think a mobile check-in format is something that would realistically work for my lifestyle, or would I do better with a more structured in-person program?
5Now that this trial is completed, is there any way I could access a similar mobile cardiac rehabilitation support program based on what was studied here, or is standard cardiac rehab the best path forward for me right now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Metabolic Equivalents of Task (METS)
Timeframe: Baseline; 3 Months
2
Number of Participants Who Were Re-hospitalized During the Trial